Introduction Antipsychotics have had a history of being prescribed at a high rate in nursing homes(NH). 30% of all newly-admitted NH residents received antipsychotic medications in 2006. In 2012, Centers for Medicare & Medicaid Services (CMS) launched the Partnership to Improve Dementia Care in Nursing Homes to promote comprehensive dementia care and therapeutic interventions for NH residents with dementia-related behaviors in partnership with various national organizations. The appropriate use of the medication is still an uneven practice and clinicians often are unclear when to start, continue or stop the medication. We endeavor to present the outcomes following the implementation of the guidelines at our facility. Methods In an 800 bed facility, the psychiatrists implemented a user-friendly objective medication guideline in the management of BPSD, while concurrently providing staff education to the frontline staff beginning 2011.The elements of the guideline include - a) non-medication interventions, b) when to start, continuation and discontinuation criteria. We reviewed changes in antipsychotic medication rate over the past 7 years at the facility while comparing the commensurate national data available in CMS archives from quarter 1 of 2011 (2011Q1) to quarter 1 of 2018 (2018Q1). Results Point prevalence of antipsychotics at the facility in Q1 of each year were 38%(2011), 25%(2012), 12.9%(2013), 13.6%(2014), 14.1%(2015), 14.55%(2016), 11.67%(2017) and 9.14%(2018). The national point prevalence during the same duration were 23.6%(2011), 23.8%(2012), 21.64%(2013), 19.79%(2014), 18.68%(2015), 16.6%(2016), 15.7%(2017) and 14.8%(2018). The point prevalence for the facility went down from 38% in Q1 of 2011 to 9.14% in Q1 of 2018, a decrease of 76%. The national point prevalence during the same duration of 7 years decreased from 23.6% to 14.8%, a decline of 37%. The prevalence for the facility has registered a faster decline than the national average (76% vs 37%). The prevalence of antipsychotics was higher for the facility in 2011 (38% vs 23.6%) and 2012 (25% vs 23.8%) compared to the national average. We are collecting data for the rate of use of psychotropics other than antipsychotics in the management of BPSD at the facility. Conclusions Psychiatry can play a significant role in implementing appropriate medication use guidelines while providing in-vivo education to the primary care team. The guidelines help provide an objective standardized manner of right-sizing the dose or appropriate usage of the medication. It helps involve all stakeholders, including, the psychiatrist, primary care provider, nursing and family, in providing adequate care to the NH residents. Using an objective behavior assessment tool (Neuropsychiatric Inventory Questionnaire - NPI) may further improve medication prescribing practices. The pattern of prescription of other classes of psychotropics will also help rationalize appropriate behavioral management. This research was funded by None.